Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36048453

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2022 Nov 1
First author
Conroy T

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2023 Jan 1;9(1):151. doi: 10.1001/jamaoncol.2022.6629.
    note
    Source null
    related pmid
    36416803
    relationship
    Erratum in

Authors and identifiers

  1. name
    Conroy T
    type
    Author
  2. name
    Castan F
    type
    Author
  3. name
    Lopez A
    type
    Author
  4. name
    Turpin A
    type
    Author
  5. name
    Ben Abdelghani M
    type
    Author
  6. name
    Wei AC
    type
    Author
  7. name
    Mitry E
    type
    Author
  8. name
    Biagi JJ
    type
    Author
  9. name
    Evesque L
    type
    Author
  10. name
    Artru P
    type
    Author
  11. name
    Lecomte T
    type
    Author
  12. name
    Assenat E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Conroy T
    type
    Author
  2. name
    Castan F
    type
    Author
  3. name
    Lopez A
    type
    Author
  4. name
    Turpin A
    type
    Author
  5. name
    Ben Abdelghani M
    type
    Author
  6. name
    Wei AC
    type
    Author
  7. name
    Mitry E
    type
    Author
  8. name
    Biagi JJ
    type
    Author
  9. name
    Evesque L
    type
    Author
  10. name
    Artru P
    type
    Author
  11. name
    Lecomte T
    type
    Author
  12. name
    Assenat E
    type
    Author
bibliography ids
  1. nci-bib-e5d2144c63790bf83e15366a
book metadata
content sha256
0d7ae2a0f6e4c404660ac2bd7802aa1d54d13d01aa7ee094be3b65def453fe48
document type
citation
dois
  1. 10.1001/jamaoncol.2022.3829
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36048453
immutable id
pubmed:36048453@0d7ae2a0f6e4c404660ac2bd7802aa1d54d13d01aa7ee094be3b65def453fe48
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
11
name
JAMA oncology
nlm unique id
101652861
pages
1571-1578
volume
8
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2023 Jan 1;9(1):151. doi: 10.1001/jamaoncol.2022.6629.
    note
    Source null
    related pmid
    36416803
    relationship
    Erratum in
outcomes validated
false
pmid
36048453
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
9ba34b09e7e7652860a9ff5b1602b34ee972630a6b52a96c747c84328d7b4c4d
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Nov 1
precision
day
year
2022
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36048453/
title
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.

Preserved source evidence · Not medical advice